MLSS Milestone Scientific Inc

Price (delayed)

$0.696

Market cap

$53.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$50.73M

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary ...

Highlights
The gross profit is up by 39% year-on-year and by 7% since the previous quarter
The company's gross margin rose by 24% YoY and by 6% QoQ
The company's quick ratio fell by 28% YoY but it rose by 28% QoQ
The equity has contracted by 22% YoY but it has grown by 11% from the previous quarter

Key stats

What are the main financial stats of MLSS
Market
Shares outstanding
76.6M
Market cap
$53.32M
Enterprise value
$50.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.17
Price to sales (P/S)
5.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.16
Earnings
Revenue
$9.83M
EBIT
-$7.05M
EBITDA
-$6.9M
Free cash flow
-$5.33M
Per share
EPS
-$0.1
Free cash flow per share
-$0.07
Book value per share
$0.11
Revenue per share
$0.14
TBVPS
$0.15
Balance sheet
Total assets
$11.37M
Total liabilities
$3.36M
Debt
$395,978
Equity
$8.01M
Working capital
$7.72M
Liquidity
Debt to equity
0.05
Current ratio
3.51
Quick ratio
2.04
Net debt/EBITDA
0.37
Margins
EBITDA margin
-70.3%
Gross margin
69.1%
Net margin
-70.5%
Operating margin
-72.3%
Efficiency
Return on assets
-61.1%
Return on equity
-84.8%
Return on invested capital
-122.2%
Return on capital employed
-85%
Return on sales
-71.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MLSS stock price

How has the Milestone Scientific stock price performed over time
Intraday
8.75%
1 week
22.11%
1 month
9.68%
1 year
-7.2%
YTD
0.88%
QTD
11.72%

Financial performance

How have Milestone Scientific's revenue and profit performed over time
Revenue
$9.83M
Gross profit
$6.79M
Operating income
-$7.11M
Net income
-$6.93M
Gross margin
69.1%
Net margin
-70.5%
The gross profit is up by 39% year-on-year and by 7% since the previous quarter
The net margin has grown by 29% YoY
The operating margin has increased by 28% year-on-year
The company's gross margin rose by 24% YoY and by 6% QoQ

Growth

What is Milestone Scientific's growth rate over time

Valuation

What is Milestone Scientific stock price valuation
P/E
N/A
P/B
6.17
P/S
5.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.16
Milestone Scientific's EPS has increased by 17% YoY but it has decreased by 11% from the previous quarter
The P/B is 60% lower than the 5-year quarterly average of 15.3 and 17% lower than the last 4 quarters average of 7.4
The equity has contracted by 22% YoY but it has grown by 11% from the previous quarter
The P/S is 54% less than the 5-year quarterly average of 11.3 and 21% less than the last 4 quarters average of 6.5
The revenue is up by 12% year-on-year

Efficiency

How efficient is Milestone Scientific business performance
The company's return on invested capital has surged by 69% YoY and by 16% QoQ
Milestone Scientific's ROS has increased by 28% YoY
The return on equity has declined by 20% year-on-year and by 6% since the previous quarter
MLSS's ROA is down by 13% YoY and by 4.6% QoQ

Dividends

What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MLSS.

Financial health

How did Milestone Scientific financials performed over time
The company's quick ratio fell by 28% YoY but it rose by 28% QoQ
The total assets has declined by 17% year-on-year but it has increased by 7% since the previous quarter
The debt is 95% less than the equity
The equity has contracted by 22% YoY but it has grown by 11% from the previous quarter
The debt has contracted by 20% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.